2020
DOI: 10.1358/dof.2020.45.1.3127029
|View full text |Cite
|
Sign up to set email alerts
|

Recent Clinical Disclosures and SMR Award. Highlights from The Society for Medicines Research Symposium. London, UK - December 5, 2019

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Recent advancements in peptide solid-phase synthesis, phage display technology, computer simulation, and computation, and more and more new tumor-targeting peptide-coupled drugs have led to the creation of such as the bicyclic peptide drug BT-1718 by Bicycle Therapeutics is a new type of peptide drug with a bicyclic structure [ 184 ], which can effectively overcome the problem of fast metabolism of ordinary peptide drugs in vivo. It is anticipated that future developments will leverage these novel peptides to create more stable or multifunctional tumor-targeting drugs.…”
Section: Discussionmentioning
confidence: 99%
“…Recent advancements in peptide solid-phase synthesis, phage display technology, computer simulation, and computation, and more and more new tumor-targeting peptide-coupled drugs have led to the creation of such as the bicyclic peptide drug BT-1718 by Bicycle Therapeutics is a new type of peptide drug with a bicyclic structure [ 184 ], which can effectively overcome the problem of fast metabolism of ordinary peptide drugs in vivo. It is anticipated that future developments will leverage these novel peptides to create more stable or multifunctional tumor-targeting drugs.…”
Section: Discussionmentioning
confidence: 99%